This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Fabry Disease: The Role of the Genetic Counselor in an Ever-Changing Landscape

Fabry Disease: The Role of the Genetic Counselor in an Ever-Changing Landscape


Slide Lecture Series

Time to Complete

45 minutes


February 25, 2019


February 25, 2020
Add to Queue

Maximum Credits

0.75 / CE for Genetic Counselors (0.07 CEUs)

Genetic Counselor Claim Credit Instructions

Your NSGC ID Number is required for participation in this course. You will be asked to provide it on the Evaluation form and will not receive full credit unless it is provided. The activity is COMPLIMENTARY for NSGC members.

To register for an NSGC ID, please go to, and select “Become a Member” from the site navigation. Please note there is a fee to become an NSGC member.

Accredited Provider

Provided by EXCEL Continuing Education

Commercial Supporter

This activity is supported by an educational grant from Sanofi-Genzyme.

Program Description

Fabry disease is the second most common lysosomal storage disorder, affecting the cells of multiple organ systems. With a high variability in disease manifestations, the disease can differ from one individual to another, making diagnosis and management a challenge. Growing evidence suggests that initiating certain treatments early in the disease process—before organ damage has ensued—may benefit clinical outcomes and reduce serious complications. Genetic counselors play an important role in providing supportive care strategies by educating patients on Fabry disease, the role of genetic testing, and how the disease can impact patient life and family members. This module will review these issues including sample patient case scenarios.

Intended Audience

Genetic Counselors

Educational Objectives

At the conclusion of this activity, participants should be able to:

  • Examine how defining the phenotype/genotype relationship can impact genetic and developmental issues
  • Discuss the symptoms, diagnosis, and treatment recommendations for managing patients with Fabry disease
  • Review genetic counseling issues, genetic testing, and inheritance patterns and screening recommendations for Fabry disease

Conflict Of Interest Disclosure Policy

EXCEL Continuing Education requires all those who are in a position to control the content of this activity including faculty, planners, peer reviewers, and EXCEL staff to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to EXCEL policy.


Dawn Jacob Laney, MS, CGC, CCRC
Assistant Professor /Genetic Counselor
Genetic Clinical Trials Center Director
LSDC Program Leader
Emory Department of Human Genetics
Emory University
Atlanta, GA

Ms. Laney has disclosed that she has received honoraria and research funding as an investigator, researcher, speaker, board member registries/coordinator for Sanofi Genzyme; has received research funding and honoraria as an investigator, speaker, coordinator for Amicus and Shire, now part of Takeda; and is a co-founder and has stock options for Thinkgenetic, Inc.




CE Credit

Accreditation Statement

The National Society of Genetic Counselors (NSGC) has authorized EXCEL CONTINUING EDUCATION to offer up to 0.07 CEUs or 0.75 Category 1 contact hours for the activity The Role of the Genetic Counselor in Pompe Disease. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


To obtain credit, a score of 80% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For questions regarding this activity, please contact EXCEL Continuing Education at or phone (305) 630-9414.

Privacy Policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue